Clinical Immunology, Neuropharmacology and Drug Development

Epigenetic Modulation in Neuroimmune Disorders

This track invites researchers to submit abstracts on the role of epigenetic changes in neuroimmune disorders and the potential for therapeutic intervention. Topics may include the identification of epigenetic markers, the development of drugs targeting epigenetic modifications, and the impact of environmental factors on the epigenetic regulation of neuroimmune responses. Attendees will explore how epigenetic mechanisms can be leveraged to develop novel treatments for diseases such as multiple sclerosis, epilepsy, and neuroinflammatory conditions, offering new avenues for therapy that go beyond traditional pharmacological approaches.